Free Trial
CVE:PDP

Pediapharm (PDP) Stock Price, News & Analysis

Pediapharm logo
C$0.30
+0.01 (+1.69%)
(As of 12/18/2018)

About Pediapharm Stock (CVE:PDP)

Key Stats

Today's Range
C$0.29
C$0.31
50-Day Range
C$0.30
C$0.30
52-Week Range
C$0.25
C$0.49
Volume
26,000 shs
Average Volume
100,369 shs
Market Capitalization
C$66.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.

Receive PDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediapharm and its competitors with MarketBeat's FREE daily newsletter.

PDP Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

PDP Stock Analysis - Frequently Asked Questions

Pediapharm's stock was trading at C$0.30 at the start of the year. Since then, PDP stock has increased by 0.0% and is now trading at C$0.30.
View the best growth stocks for 2024 here
.

Shares of PDP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pediapharm investors own include Medexus Pharmaceuticals (MEDXF), iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX), Enzo Biochem (ENZ), eMagin (EMAN), Eleven Biotherapeutics (EBIO), Coro Mining (COP) and Champion Iron (CIA).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$11.16 million
Cash Flow
C$0.01 per share
Book Value
C($0.01) per share

Miscellaneous

Free Float
N/A
Market Cap
C$66.36 million
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (CVE:PDP) was last updated on 10/30/2024 by MarketBeat.com Staff
From Our Partners